---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-088663"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2025-09-09T23:59:59+00:00"
generated_at: "2026-05-17T07:18:26.842739+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics replaces Interim CEO; appoints Jason D. Sawyer

## Summary
- Richard Joel Paolone terminated as Interim CEO and Chairman, effective Sept 3, 2025, without cause.
- Paolone remains as director; consulting agreement terminated with payment in lieu of notice.
- Jason D. Sawyer appointed Interim CEO effective Sept 4, 2025; continues as director.
- Sawyer has 32-year investment background; currently Head of Finance & M&A at Quantum BioPharma.

## SEC filing metadata
- accession: 0001104659-25-088663
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2025-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465925088663/0001104659-25-088663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465925088663/tm2525441-1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-088663
- JSON: https://secwatch.observer/filing/0001104659-25-088663.json
- Plain text: https://secwatch.observer/filing/0001104659-25-088663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.